Drug profile · INN
pomalidomide
POMALIDOMIDE SANDOZ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pomalidomide (POMALIDOMIDE SANDOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN pomalidomide
Brand POMALIDOMIDE SANDOZ
Route ORAL
Formulation CAPSULE
ATC code L04AX06
Originator Lacuna Pharma Pty Ltd
Frequently asked questions
What is pomalidomide?
pomalidomide (POMALIDOMIDE SANDOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pomalidomide?
POMALIDOMIDE SANDOZ is a marketed brand name for pomalidomide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pomalidomide?
pomalidomide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.